Jianfeng Duan

Jianfeng Duan


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2023 in Metabolites
Verified
Journal Article
Open access
PDF file
YXYali Xu
Yali Xu
JDJianfeng Duan
Jianfeng Duan
DWDacheng Wang
Dacheng Wang
JLJiali Liu
Jiali Liu
XCXiancheng Chen
Xiancheng Chen
WYWenkui Yu
Wenkui Yu
Many patients in intensive care units, especially the elderly, suffer from chronic critical illness and exhibit a new pathophysiological phenotype: persistent inflammation, immunosuppression, and catabolism syndrome (PICS). Most patients with PICS have a constellation of digestive-system symptoms and gut failure. Akkermansia muciniphila (Akk) is a commensal gut bacterium that reduces inflammation, balances immune responses, modulates energy metabolism, and supports gut health. This study investigated the protective effects and underlying mechanisms of live and pasteurized Akk in treating PICS in a mouse model. PICS was induced on day 14 after performing cecal ligation and puncture (CLP) on day 1 and administrating lipopolysaccharide on day 11. Pasteurized or live Akk, or phosphate-buffered saline was administered twice daily by oral gavage for 7 days. Both live and pasteurized Akk attenuated PICS, as evidenced by reduced weight loss, and a reduction in symptoms and serum cytokine/chemokine levels. Liver and intestinal injuries were mitigated, and intestinal barrier integrity improved with Akk administration. Analysis of 16S rRNA amplicon sequences showed that Akk induced significant intestinal microbiota alterations, including increased abundance of Akk, Muribaculaceae, Parabacterbides goldsteinii, and decreased abundance of Escherichia_Shigella and Enterobacteriaceae. Collectively, Akk alleviates PICS by enhancing gut barrier function and reshaped the microbial community.

22 September 2025 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Open access
JCJiawen Chen
Jiawen Chen
JLJiali Liu
Jiali Liu
GWGang Wang
Gang Wang
XLXinran Liang
Xinran Liang
YXYuanbo Xue
Yuanbo Xue
WYWenkui Yu
Wenkui Yu
Persistent inflammation, immunosuppression, and catabolism syndrome (PIICS) drives severe metabolic dysregulation and hepatic injury, characterized by hepatocyte damage and fibrosis. While curcumin (CUR) exhibits hepatoprotective properties, its role in PIICS-induced liver injury remains unexplored. This study investigates the efficacy and mechanisms of CUR against PIICS-induced hepatic damage. Murine PIICS models underwent hepatic histopathology (H&E staining, TEM), RNA sequencing, and targeted metabolomics to identify injury markers. CUR's effects were assessed via biochemical, transcriptomic, and metabolomic analyses. Network pharmacology, molecular docking, and qPCR were employed to validate CUR targets. PIICS mice exhibited elevated serum ALT, AST, IL-6, and TNF-α levels, alongside histopathological evidence of inflammatory infiltration. Transcriptomics revealed dysregulation in lipid metabolism, redox homeostasis, and iron-binding pathways. Metabolomics identified hepatic polyunsaturated fatty acid (PUFA) depletion, increased ferrous ions, lipid peroxidation (4-HNE, MDA), and reduced antioxidants (GSH, SOD). CUR treatment alleviated liver injury, restored redox balance, and suppressed ferroptosis markers. Integrated analyses demonstrated that CUR targets ferroptosis-related pathways, modulating lipid metabolism, iron homeostasis, and oxidative stress. CUR mitigates PIICS-induced liver injury by counteracting ferroptosis through modulation of lipid metabolism, iron homeostasis, and oxidative stress, offering a promising therapeutic strategy.

2 January 2025 in Burns & Trauma
Verified
Journal Article
Open access
GWGang Wang
Gang Wang
TGTao Gao
Tao Gao
YLYijiang Liu
Yijiang Liu
JDJianfeng Duan
Jianfeng Duan
HLHuimin Lu
Huimin Lu
WYWenkui Yu
Wenkui Yu
Background: Non-thyroidal illness syndrome is commonly observed in critically ill patients, characterized by the inactivation of systemic thyroid hormones (TH), which aggravates metabolic dysfunction. Recent evidence indicates that enhanced TH inactivation is mediated by the reactivation of type 3 deiodinase (Dio3) at the tissue level, culminating in a perturbed local metabolic equilibrium. This study assessed whether targeted inhibition of Dio3 can maintain tissue metabolic homeostasis under septic conditions and explored the mechanism behind Dio3 reactivation. Methods: A retrospective clinical study was conducted to investigate the attributes of rT3. The expression of Dio3 was detected by immunoblotting, immunofluorescence, and immunohistochemical staining in tissues extracted from CLP-induced septic rats and human biopsy samples. In addition, the effect of Dio3 inhibition on skeletal muscle metabolism was observed in rats with targeted Dio3 knockdown using an adeno-associated virus. The effectiveness of Sonic hedgehog (Shh) signaling inhibition on systemic TH levels was observed in CLP-induced septic rats receiving cyclopamine. The mechanisms underlying such inhibition were explored using immunoblotting, RNA-seq, and chromatin immunoprecipitation–qPCR assays. Results: The main product of Dio3, rT3, is strongly associated with organ function. Early sepsis leads to significant upregulation of Dio3 in the skeletal muscles and lung tissues of septic rats. The targeted inhibition of Dio3 in skeletal muscle restores TH responsiveness, prevents fast-to-slow fiber conversion, preserves glucose transporter type 4 functionality, and maintains metabolic balance between protein synthesis and proteolysis, which leads to preserved muscle mass. The reactivation of Dio3 is transcriptionally regulated by the Shh pathway induced by the signal transducer and activator of transcription 3. Conclusions: The suppression of Dio3 restores tissue TH actions, attenuates proteolysis, and ameliorates anabolic resistance in the skeletal muscles of septic rats, thereby improving local metabolic homeostasis. Our results provide insights into the mechanisms of Dio3 reactivation and its critical role in local metabolic alterations induced by sepsis, while also suggesting novel targets aimed at ameliorating tissue-specific metabolic disorders.

4 September 2025 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
JLJiali Liu
Jiali Liu
YXYali Xu
Yali Xu
YXYun Xu
Yun Xu
JCJiawen Chen
Jiawen Chen
JDJianfeng Duan
Jianfeng Duan
WYWenkui Yu
Wenkui Yu
To elucidate determinants of suboptimal early nutritional support achievement in critical illness. 403 adult ICU patients receiving nutritional support during days 1–7 of admission were enrolled in this retrospective study. For patients, basic patient information, disease severity, inflammatory indicators, and prognostic indicators were collected to explore the reasons for the poor rate of early nutritional support. In addition to observing ICU patients, adult male SD rats were injected with LPS dissolved in saline (10 mg/kg) via a single intraperitoneal injection to simulate the inflammatory state caused by human infection. Skeletal muscle tissues and hypothalamic tissues of rats at different time point (6, 12, and 24 h) s were taken for methylation assay, respectively. The baseline APACHE II (24.45 vs. 21.17, p < 0.001) and CRP (126.44 vs. 88.00 mg/L, p < 0.001) were significantly higher in the non-achieving group (failed to meet 80% target calories by day 7) than in the target-achieving group. Inverse correlations existed between caloric delivery and inflammatory markers (WBC: r = −0.313; CRP: r = −0.311). Septic rats exhibited time-dependent hypothalamic promoter methylation changes absent in skeletal muscle. Systemic inflammation and disease severity constitute primary barriers to nutritional target achievement, potentially mediated through central epigenetic regulation.